Daily Briefing

Healthgrades recently released its National Health Index—a list of the 100 cities in the United States that are 'getting health care right.' See if your city made the list. More

While women make up 80% of the health care workforce, 'only a small fraction of female physicians become medical leaders,' Lisa Rotenstein writes in Harvard Business Review. Advisory Board's Veena Lanka provides four ways that health care leaders can address this problem within their existing initiatives and 'without having to launch yet another standalone campaign.' More

"[I]s it time for doctors to pull out their prescription pads and … start prescribing democracy?" That's the controversial idea put forth by physician Danielle Ofri in a recent New York Times opinion piece—but her proposal has drawn pushback from commentators on both sides of the aisle. More

Mayo Clinic's Comprehensive Stroke Center Practice is lowering the cost of caring for stroke patients by stratifying patients based on their clinical needs before they go to the ICU. More

The Trump administration this week announced new efforts to combat the U.S. opioid epidemic, as President Trump signed into law a sweeping, bipartisan bill to address opioid misuse. More

FDA on Wednesday approved Genentech's antiviral influenza treatment Xofluza. More

FDA data show the agency approved 781 generic drugs in fiscal year (FY) 2018, breaking the agency's previous record of 763 generic drug approvals in FY 2017. More

An accountable care organization projected to reap $4.8 million in savings for Fort Worth, Texas; join our web conference to learn how to strengthen primary care access; and more. More

The price of the drug, Repatha, will go from $14,100 to $5,850 annually, in today's bite-sized hospital and health industry news from California and Texas. More